| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026589421 |
| P356 | DOI | 10.1007/S10354-010-0848-4 |
| P698 | PubMed publication ID | 21170698 |
| P5875 | ResearchGate publication ID | 225156701 |
| P2093 | author name string | Matthias Unger | |
| P2860 | cites work | Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide | Q24651117 |
| Effects of St. John's wort on irinotecan metabolism | Q33184162 | ||
| Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. | Q33907273 | ||
| Inhibition of human cytochromes P450 by components of Ginkgo biloba | Q34337497 | ||
| In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes | Q34419646 | ||
| Hyperforin in St. John's wort drug interactions | Q34494412 | ||
| St John's wort (Hypericum perforatum): drug interactions and clinical outcomes | Q34976869 | ||
| Interaction of St John's wort with conventional drugs: systematic review of clinical trials | Q35615173 | ||
| Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba | Q35765836 | ||
| Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients | Q35846658 | ||
| Effects of dietary factors on drug transport and metabolism: the impact on dosage guidelines in transplant patients | Q37395763 | ||
| The drug transporter-metabolism alliance: uncovering and defining the interplay | Q37485904 | ||
| Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members | Q41376777 | ||
| Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin | Q43830741 | ||
| Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients | Q44362349 | ||
| Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers | Q44697443 | ||
| St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole | Q44787217 | ||
| Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases | Q44904677 | ||
| Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers | Q45029658 | ||
| In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. | Q45146006 | ||
| Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers | Q46082217 | ||
| Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers | Q46120062 | ||
| No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract | Q46459610 | ||
| Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan | Q46797231 | ||
| Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate | Q46908034 | ||
| The effect of silymarin on oral nifedipine pharmacokinetics | Q46925084 | ||
| Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) | Q73145709 | ||
| Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation | Q73246112 | ||
| Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha) | Q73553912 | ||
| P433 | issue | 21-22 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 571-577 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Wiener Medizinische Wochenschrift | Q2568998 |
| P1476 | title | Pharmacokinetic drug interactions by herbal drugs: Critical evaluation and clinical relevance | |
| P478 | volume | 160 |
| Q83274402 | Drug interactions with herbal medicines |
| Q40727097 | Drug safety aspects of herbal medicinal products |
| Q38122439 | Pharmacokinetic drug interactions involving Ginkgo biloba |
| Q36190989 | Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin |
| Q33908231 | Valerian: no evidence for clinically relevant interactions. |
| Q83970457 | [Drug-drug interactions in antirheumatic treatment] |
Search more.